Matches in Nanopublications for { ?s ?p "PKC alpha was activated by Heregulin treatment. Ectopic expression of wild type PKC-alpha attenuated the apoptosis generated by HRG and GF109203 (PKC inhibitor). Apoptotic cells were reduced from 42.8% in control transfected cells to 26.8% in PKC-alpha transfected cells. Heregulin induced 10.8% apoptosis whereas a combination of Heregulin and PKC inhibitors GF109203 and HRG induced 20.7% apoptosis. PKC functional impairment increases Heregulin-induced apoptosis." ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- _4 value "PKC alpha was activated by Heregulin treatment. Ectopic expression of wild type PKC-alpha attenuated the apoptosis generated by HRG and GF109203 (PKC inhibitor). Apoptotic cells were reduced from 42.8% in control transfected cells to 26.8% in PKC-alpha transfected cells. Heregulin induced 10.8% apoptosis whereas a combination of Heregulin and PKC inhibitors GF109203 and HRG induced 20.7% apoptosis. PKC functional impairment increases Heregulin-induced apoptosis." provenance.
- _4 value "PKC alpha was activated by Heregulin treatment. Ectopic expression of wild type PKC-alpha attenuated the apoptosis generated by HRG and GF109203 (PKC inhibitor). Apoptotic cells were reduced from 42.8% in control transfected cells to 26.8% in PKC-alpha transfected cells. Heregulin induced 10.8% apoptosis whereas a combination of Heregulin and PKC inhibitors GF109203 and HRG induced 20.7% apoptosis. PKC functional impairment increases Heregulin-induced apoptosis." provenance.